SIEMENS HEALTHINEERS AG lowered its 2026 revenue growth forecast to 4.5%–5.0% following a 3.3% share price drop. The revision from the previous 5%–6% range follows a 6.5% revenue decline in the diagnostics division to 985 million euros. Reduced EPS guidance and a potential diagnostics spin-off reflect investor concerns over structural headwinds.

China Pricing Pressure Hits Diagnostics